Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China
· Delayed Price · Currency is CNY 15.71
+0.01 (0.06%)
Mar 10, 2026, 12:54 PM CST
SHE:300497 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 632.74 | 695.35 | 729.37 | 978.03 | 1,272 | 1,585 | Upgrade
|
| Trading Asset Securities | 1.98 | 2.19 | 2.19 | 49.74 | 150.76 | 106.68 | Upgrade
|
| Cash & Short-Term Investments | 634.71 | 697.54 | 731.56 | 1,028 | 1,423 | 1,692 | Upgrade
|
| Cash Growth | -6.23% | -4.65% | -28.82% | -27.79% | -15.88% | 105.98% | Upgrade
|
| Accounts Receivable | 420.04 | 498.16 | 572.92 | 552.49 | 376.21 | 314.38 | Upgrade
|
| Other Receivables | 44.69 | 53.85 | 128.31 | 78.21 | 80.01 | 57.44 | Upgrade
|
| Receivables | 464.73 | 552.01 | 701.23 | 630.71 | 456.22 | 371.82 | Upgrade
|
| Inventory | 406.04 | 421.05 | 434.68 | 553.69 | 416.15 | 287.98 | Upgrade
|
| Other Current Assets | 18.88 | 10.42 | 9.97 | 17.11 | 15.97 | 14.98 | Upgrade
|
| Total Current Assets | 1,524 | 1,681 | 1,877 | 2,229 | 2,312 | 2,367 | Upgrade
|
| Property, Plant & Equipment | 2,281 | 2,267 | 2,331 | 2,201 | 1,857 | 1,199 | Upgrade
|
| Long-Term Investments | 251.19 | 255.9 | 271.27 | 271.42 | 133.02 | 153.78 | Upgrade
|
| Goodwill | - | - | - | 1.15 | 2.22 | 2.22 | Upgrade
|
| Other Intangible Assets | 289.31 | 235 | 241.07 | 249.71 | 256.32 | 246.28 | Upgrade
|
| Long-Term Deferred Tax Assets | 31.1 | 37.26 | 29.37 | 28.49 | 27.54 | 9.29 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 2.2 | Upgrade
|
| Other Long-Term Assets | 60.55 | 60.95 | 69.13 | 78.79 | 90.82 | 66.71 | Upgrade
|
| Total Assets | 4,438 | 4,537 | 4,819 | 5,060 | 4,678 | 4,046 | Upgrade
|
| Accounts Payable | 384.37 | 603.37 | 581.93 | 656.67 | 517.05 | 418.6 | Upgrade
|
| Accrued Expenses | 15.82 | 44.05 | 44.52 | 42.4 | 51.97 | 37.75 | Upgrade
|
| Short-Term Debt | 631.39 | 556.4 | 549.83 | 366.74 | 615.18 | 377.38 | Upgrade
|
| Current Portion of Long-Term Debt | 260.9 | 311.78 | 78.78 | 7.96 | 33.5 | - | Upgrade
|
| Current Income Taxes Payable | 10.69 | 0.05 | 0.82 | 8.71 | 13.89 | 42.11 | Upgrade
|
| Current Unearned Revenue | 3.29 | 2.72 | 3.4 | 1.42 | 1.82 | 2.81 | Upgrade
|
| Other Current Liabilities | 25.25 | 25.46 | 26.32 | 174.96 | 126.56 | 6.25 | Upgrade
|
| Total Current Liabilities | 1,332 | 1,544 | 1,286 | 1,259 | 1,360 | 884.9 | Upgrade
|
| Long-Term Debt | 829.47 | 736.48 | 998.26 | 1,043 | 353 | 65 | Upgrade
|
| Long-Term Unearned Revenue | 106.89 | 77.67 | 62.39 | 62.03 | 50.3 | 43.73 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.89 | 1.96 | 2.05 | 6.27 | 3.92 | 4.3 | Upgrade
|
| Total Liabilities | 2,270 | 2,360 | 2,348 | 2,370 | 1,767 | 997.93 | Upgrade
|
| Common Stock | 538.65 | 550 | 550 | 550 | 550 | 550 | Upgrade
|
| Additional Paid-In Capital | 1,247 | 1,381 | 1,414 | 1,408 | 1,406 | 1,465 | Upgrade
|
| Retained Earnings | 346.03 | 408.78 | 680.88 | 881.68 | 1,023 | 1,084 | Upgrade
|
| Treasury Stock | - | -174.86 | -174.86 | -174.86 | -105.11 | -100.02 | Upgrade
|
| Comprehensive Income & Other | 16.82 | 15.45 | 14.3 | 16.89 | 6.08 | 8.34 | Upgrade
|
| Total Common Equity | 2,149 | 2,180 | 2,485 | 2,681 | 2,880 | 3,007 | Upgrade
|
| Minority Interest | 19.39 | -3.54 | -14.06 | 8.4 | 31.1 | 40.39 | Upgrade
|
| Shareholders' Equity | 2,168 | 2,177 | 2,471 | 2,690 | 2,911 | 3,048 | Upgrade
|
| Total Liabilities & Equity | 4,438 | 4,537 | 4,819 | 5,060 | 4,678 | 4,046 | Upgrade
|
| Total Debt | 1,722 | 1,605 | 1,627 | 1,418 | 1,002 | 442.38 | Upgrade
|
| Net Cash (Debt) | -1,087 | -907.13 | -895.31 | -389.97 | 421.54 | 1,249 | Upgrade
|
| Net Cash Growth | - | - | - | - | -66.26% | 957.75% | Upgrade
|
| Net Cash Per Share | -2.02 | -1.70 | -1.65 | -0.72 | 0.78 | 2.70 | Upgrade
|
| Filing Date Shares Outstanding | 538.65 | 538.65 | 538.65 | 538.65 | 538.65 | 540.73 | Upgrade
|
| Total Common Shares Outstanding | 538.65 | 538.65 | 538.65 | 538.65 | 543.13 | 540.73 | Upgrade
|
| Working Capital | 192.67 | 137.2 | 591.84 | 970.42 | 951.59 | 1,482 | Upgrade
|
| Book Value Per Share | 3.99 | 4.05 | 4.61 | 4.98 | 5.30 | 5.56 | Upgrade
|
| Tangible Book Value | 1,859 | 1,945 | 2,244 | 2,430 | 2,622 | 2,759 | Upgrade
|
| Tangible Book Value Per Share | 3.45 | 3.61 | 4.17 | 4.51 | 4.83 | 5.10 | Upgrade
|
| Buildings | - | 936.67 | 836.72 | 712.09 | 471.86 | 384.81 | Upgrade
|
| Machinery | - | 1,641 | 1,423 | 1,232 | 851.39 | 621.88 | Upgrade
|
| Construction In Progress | - | 457.86 | 695.78 | 736.4 | 922.19 | 494.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.